Published Date: 02 Mar 2023
According to a recent study by researchers at the University of Michigan, 71% of 2,000 Americans (aged 50-80) surveyed said they held beliefs that were important to them.
Read Full NewsThe rheumatology year in review highlights FDA approvals and pivotal data readouts.
Johnson & Johnson plans to initiate a phase 3 study based off the positive data.
Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.
Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.
The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.
Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101
Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression
1.
enhancing survivors of brain tumors' quality of life.
2.
Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.
3.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
4.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
5.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
1.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
2.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
3.
The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy
4.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
5.
Understanding QSOFA: A Vital Tool for Recognizing Sepsis
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Oropharyngeal Cancer in Relation to HPV Status
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation